World Scientific
  • Search
    Quick Search in Journals
    Access type:
    Quick Search anywhere
    Access type:
    Advanced Search
  • My Cart
  •   
Skip main navigation
Close Drawer MenuOpen Drawer Menu

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

Our site uses Javascript to enchance its usability.You can disable your ad blocker or whitelist our website www.worldscientific.com to view the full content.

Select your blocker:

Adblock Plus Instructions

  1. Click the AdBlock Plus icon in the extension bar
  2. Click the blue power button
  3. Click refresh
Our website is made possible by displaying certain online content using javascript.
In order to view the full content, please disable your ad blocker or whitelist our website www.worldscientific.com.

System Upgrade on Tue, Oct 25th, 2022 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at [email protected] for any enquiries.
Open Access

The Role of Ophiopogonin D in Atherosclerosis: Impact on Lipid Metabolism and Gut Microbiota

    https://doi.org/10.1142/S0192415X21500683Cited by:11 (Source: Crossref)
    Previous
    Next

    Abstract

    Gut microbiota has been proven to play an important role in many metabolic diseases and cardiovascular disease, particularly atherosclerosis. Ophiopogonin D (OPD), one of the effective compounds in Ophiopogon japonicus, is considered beneficial to metabolic syndrome and cardiovascular diseases. In this study, we have illuminated the effect of OPD in ApoE knockout (ApoE−/−) mice on the development of atherosclerosis and gut microbiota. To investigate the potential ability of OPD to alleviate atherosclerosis, 24 eight-week-old male ApoE−/− mice (C57BL/6 background) were fed a high-fat diet (HFD) for 12 weeks, and 8 male C57BL/6 mice were fed a normal diet, serving as the control group. ApoE−/− mice were randomly divided into the model group, OPD group, and simvastatin group (n= 8). After treatment for 12 consecutive weeks, the results showed that OPD treatment significantly decreased the plaque formation and levels of serum lipid compared with those in the model group. In addition, OPD improved oral glucose tolerance and insulin resistance as well as reducing hepatocyte steatosis. Further analysis revealed that OPD might attenuate atherosclerosis through inhibiting mTOR phosphorylation and the consequent lipid metabolism signaling pathways mediated by SREBP1 and SCD1 in vivo and in vitro. Furthermore, OPD treatment led to significant structural changes in gut microbiota and fecal metabolites in HFD-fed mice and reduced the relative abundance of Erysipelotrichaceae genera associated with cholesterol metabolism. Collectively, these findings illustrate that OPD could significantly protect against atherosclerosis, which might be associated with the moderation of lipid metabolism and alterations in gut microbiota composition and fecal metabolites.

    References

    • Alves, M.T., M.M.O. Ortiz, G.V.O.P. Dos Reis, L.M.S. Dusse, M.D.G. Carvalho, A.P. Fernandes and K.B. Gomes . The dual effect of C-peptide on cellular activation and atherosclerosis: Protective or not?. Diabetes Metab. Res. Rev. 35: e3071, 2019. Crossref, Medline, Web of Science, Google Scholar
    • Ardiansyah , Y. Inagawa, T. Koseki, A.Z. Agista, I. Ikeda, T. Goto, M. Komai and H. Shirakawa . Adenosine and adenosine-5’-monophosphate ingestion ameliorates abnormal glucose metabolism in mice fed a high-fat diet. BMC Complement. Altern. Med. 18: 304, 2018. Crossref, Medline, Web of Science, Google Scholar
    • Cao, W., Y. Chin, X. Chen, Y. Mi, C. Xue, Y. Wang and Q. Tang . The role of gut microbiota in the resistance to obesity in mice fed a high fat diet. Int. J. Food Sci. Nutr. 71: 453–463, 2020. Crossref, Medline, Web of Science, Google Scholar
    • Ceriello, A. and E. Motz . Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol. 24: 816–823, 2004. Crossref, Medline, Web of Science, Google Scholar
    • Chen, S., X. Li, L. Liu, C. Liu and X. Han . Ophiopogonin D alleviates high-fat diet-induced metabolic syndrome and changes the structure of gut microbiota in mice. FASEB J. 32: 1139–1153, 2018. Crossref, Medline, Web of Science, Google Scholar
    • Fleissner, C.K., N. Huebel, M.M.A. El-Bary, G. Loh, S. Klaus and M. Blaut . Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br. J. Nutr. 104: 919–929, 2010. Crossref, Medline, Web of Science, Google Scholar
    • Frampton, J., K.G. Murphy, G. Frost and E.S. Chambers . Short-chain fatty acids as potential regulators of skeletal muscle metabolism and function. Nat. Metab. 2: 840–848, 2020. Crossref, Medline, Google Scholar
    • Hao, T., H. Chen, S. Wu and H. Tian . LRG ameliorates steatohepatitis by activating the AMPK/mTOR/SREBP1 signaling pathway in C57BL/6J mice fed a highfat diet. Mol. Med. Rep. 20: 701–708, 2019. Medline, Web of Science, Google Scholar
    • Hills, R.D., B.A. Pontefract, H.R. Mishcon, C.A. Black, S.C. Sutton and C.R. Theberge . Gut microbiome: Profound implications for diet and disease. Nutrients 11: 1613, 2019. Crossref, Medline, Web of Science, Google Scholar
    • Huang, Q., B. Gao, L. Wang, H.Y. Zhang, X.J. Li, J. Shi, Z. Wang, J.K. Zhang, L. Yang, Z.J. Luo and J. Liu . Ophiopogonin D: A new herbal agent against osteoporosis. Bone 74: 18–28, 2015. Crossref, Medline, Web of Science, Google Scholar
    • Huang, X., Y. Wang, Z. Zhang, Y. Wang, X. Chen, Y. Wang and Y. Gao . Ophiopogonin D and EETs ameliorate Ang II-induced inflammatory responses via activating PPARalpha in HUVECs. Biochem. Biophys. Res. Commun. 490: 123–133, 2017. Crossref, Medline, Web of Science, Google Scholar
    • Javary, J., N. Allain-Courtois, N. Saucisse, P. Costet, C. Heraud, F. Benhamed, R. Pierre, C. Bure, N. Pallares-Lupon, Cruzeiro M. Do, C. Postic, D. Cota, P. Dubus, J. Rosenbaum and S. Benhamouche-Trouillet . Liver Reptin/RUVBL2 controls glucose and lipid metabolism with opposite actions on mTORC1 and mTORC2 signalling. Gut 67: 2192–2203, 2018. Crossref, Medline, Web of Science, Google Scholar
    • Jing, Y., Q. Sun, X. Xiong, R. Meng, S. Tang, S. Cao, Y. Bi and D. Zhu . Hepatocyte growth factor alleviates hepatic insulin resistance and lipid accumulation in high-fat diet-fed mice. J. Diabetes Investig. 10: 251–260, 2019. Crossref, Medline, Web of Science, Google Scholar
    • Jonsson, A.L. and F. Backhed . Role of gut microbiota in atherosclerosis. Nat. Rev. Cardiol. 14: 79–87, 2017. Crossref, Medline, Web of Science, Google Scholar
    • Khamzina, L., A. Veilleux, S. Bergeron and A. Marette . Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: Possible involvement in obesity-linked insulin resistance. Endocrinology 146: 1473–1481, 2005. Crossref, Medline, Web of Science, Google Scholar
    • Kolodziejczyk, A.A., D. Zheng, O. Shibolet and E. Elinav . The role of the microbiome in NAFLD and NASH. EMBO Mol. Med. 11: e9302, 2019. Crossref, Medline, Web of Science, Google Scholar
    • Korsheninnikova, E., G.C. van der Zon, P.J. Voshol, G.M. Janssen, L.M. Havekes, A. Grefhorst, F. Kuipers, D.J. Reijngoud, J.A. Romijn, D.M. Ouwens and J.A. Maassen . Sustained activation of the mammalian target of rapamycin nutrient sensing pathway is associated with hepatic insulin resistance, but not with steatosis, in mice. Diabetologia 49: 3049–3057, 2006. Crossref, Medline, Web of Science, Google Scholar
    • Kurdi, A., W. Martinet and G.R.Y. De Meyer . MTOR inhibition and cardiovascular diseases: Dyslipidemia and atherosclerosis. Transplantation 102: S44–S46, 2018. Crossref, Medline, Web of Science, Google Scholar
    • Lacy, M., D. Atzler, R. Liu, M. de Winther, C. Weber and E. Lutgens . Interactions between dyslipidemia and the immune system and their relevance as putative therapeutic targets in atherosclerosis. Pharmacol. Ther. 193: 50–62, 2019. Crossref, Medline, Web of Science, Google Scholar
    • Lee, J.H., C. Kim, S.G. Lee, G. Sethi and K.S. Ahn . Ophiopogonin D, a steroidal glycoside abrogates STAT3 signaling cascade and exhibits Anti-Cancer activity by causing GSH/GSSG imbalance in lung carcinoma. Cancers 10: 427, 2018. Crossref, Web of Science, Google Scholar
    • Li, X. and X. Li . Obesity promotes experimental colitis by increasing oxidative stress and mitochondrial dysfunction in the colon. Inflammation 43: 1884–1892, 2020. Crossref, Medline, Web of Science, Google Scholar
    • Liang, H., A. Mokrani, H. Chisomo-Kasiya, K. Ji, X. Ge, M. Ren, B. Liu, B. Xi and A. Sun . Dietary leucine affects glucose metabolism and lipogenesis involved in TOR/PI3K/Akt signaling pathway for juvenile blunt snout bream Megalobrama amblycephala. Fish Physiol. Biochem. 45: 719–732, 2019. Crossref, Medline, Web of Science, Google Scholar
    • Luan, H., Z. Huo, Z. Zhao, S. Zhang, Y. Huang, Y. Shen, P. Wang, J. Xi, J. Liang and F. Wu . Scutellarin, a modulator of mTOR, attenuates hepatic insulin resistance by regulating hepatocyte lipid metabolism via SREBP-1c suppression. Phytother. Res. 34: 1455–1466, 2020. Crossref, Medline, Web of Science, Google Scholar
    • Lv, Y., X. Gao, Y. Luo, W. Fan, T. Shen, C. Ding, M. Yao, S. Song and L. Yan . Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways. J. Nutr. Biochem. 71: 110–121, 2019. Crossref, Medline, Web of Science, Google Scholar
    • Mailhe, M., D. Ricaboni, V. Vitton, J.C. Lagier, P.E. Fournier and D. Raoult . “Ileibacterium massiliense” gen. Nov., Sp. Nov., A new bacterial species isolated from human ileum of a patient with Crohn disease. New Microbes New Infect. 17: 25–26, 2017. Crossref, Medline, Google Scholar
    • Mao, Z. and W. Zhang . Role of mTOR in glucose and lipid metabolism. Int. J. Mol. Sci. 19: 2043, 2018. Crossref, Web of Science, Google Scholar
    • Martinet, W., H. De Loof and G.R.Y. De Meyer . MTOR inhibition: A promising strategy for stabilization of atherosclerotic plaques. Atherosclerosis 233: 601–607, 2014. Crossref, Medline, Web of Science, Google Scholar
    • Martinez, I., D.J. Perdicaro, A.W. Brown, S. Hammons, T.J. Carden, T.P. Carr, K.M. Eskridge and J. Walter . Diet-induced alterations of host cholesterol metabolism are likely to affect the gut microbiota composition in hamsters. Appl. Environ. Microbiol. 79: 516–524, 2013. Crossref, Medline, Web of Science, Google Scholar
    • Martin-Timon, I., C. Sevillano-Collantes, A. Segura-Galindo and F.J.D. Canizo-Gomez . Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?, World J. Diabetes 5: 444–470, 2014. Crossref, Medline, Google Scholar
    • Nagy, C. and E. Einwallner . Study of in vivo glucose metabolism in high-fat diet-fed mice using oral glucose tolerance test (OGTT) and insulin tolerance test (ITT). J. Vis. Exp. 131: 56672, 2018. Google Scholar
    • Nicholson, J.K., E. Holmes, J. Kinross, R. Burcelin, G. Gibson, W. Jia and S. Pettersson . Host-gut microbiota metabolic interactions. Science 336: 1262–1267, 2012. Crossref, Medline, Web of Science, Google Scholar
    • Noureldein, M.H. and A.A. Eid . Gut microbiota and mTOR signaling: Insight on a new pathophysiological interaction. Microb. Pathog. 118: 98–104, 2018. Crossref, Medline, Web of Science, Google Scholar
    • Ohira, H., W. Tsutsui and Y. Fujioka . Are short chain fatty acids in gut microbiota defensive players for inflammation and atherosclerosis?, J. Atheroscler. Thromb. 24: 660–672, 2017. Crossref, Medline, Web of Science, Google Scholar
    • Pakala, R., E. Stabile, G.J. Jang, L. Clavijo and R. Waksman . Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice: Inhibitory effect on monocyte chemotaxis. J. Cardiovasc. Pharmacol. 46: 481–486, 2005. Crossref, Medline, Web of Science, Google Scholar
    • Paoletti, R., C. Bolego, A. Poli and A. Cignarella . Metabolic syndrome, inflammation and atherosclerosis. Vasc. Health Risk Manag. 2: 145–152, 2006. Crossref, Medline, Google Scholar
    • Park, J.E., M. Miller, J. Rhyne, Z. Wang and S.L. Hazen . Differential effect of short-term popular diets on TMAO and other cardio-metabolic risk markers. Nutr. Metab. Cardiovasc. Dis. 29: 513–517, 2019. Crossref, Medline, Web of Science, Google Scholar
    • Quan, X., L. Zhang, Y. Li and C. Liang . TCF2 attenuates FFA-induced damage in islet beta-cells by regulating production of insulin and ROS. Int. J. Mol. Sci. 15: 13317–13332, 2014. Crossref, Medline, Web of Science, Google Scholar
    • Rivera, M.E., E.S. Lyon, M.A. Johnson and R.A. Vaughan . Leucine increases mitochondrial metabolism and lipid content without altering insulin signaling in myotubes. Biochimie 168: 124–133, 2020. Crossref, Medline, Web of Science, Google Scholar
    • Sang, S., X. Zhang, H. Dai, B.X. Hu, H. Ou and L. Sun . Diversity and predictive metabolic pathways of the prokaryotic microbial community along a groundwater salinity gradient of the Pearl River Delta, China. Sci. Rep. 8: 17317, 2018. Crossref, Medline, Web of Science, Google Scholar
    • Simic, I. and Z. Reiner . Adverse effects of statins — myths and reality. Curr. Pharm. Des. 21: 1220–1226, 2015. Crossref, Medline, Web of Science, Google Scholar
    • Sonnenburg, J.L. and F. Backhed . Diet-microbiota interactions as moderators of human metabolism. Nature 535: 56–64, 2016. Crossref, Medline, Web of Science, Google Scholar
    • Spencer, M.D., T.J. Hamp, R.W. Reid, L.M. Fischer, S.H. Zeisel and A.A. Fodor . Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology 140: 976–986, 2011. Crossref, Medline, Web of Science, Google Scholar
    • Steven, S., K. Frenis, M. Oelze, S. Kalinovic, M. Kuntic, M.T. Bayo Jimenez, K. Vujacic-Mirski, J. Helmstadter, S. Kroller-Schon, T. Munzel and A. Daiber . Vascular inflammation and oxidative stress: Major triggers for cardiovascular disease. Oxid. Med. Cell. Longev. 2019: 7092151, 2019. Crossref, Medline, Web of Science, Google Scholar
    • Tang, W.H., T. Kitai and S.L. Hazen . Gut microbiota in cardiovascular health and disease. Circ. Res. 120: 1183–1196, 2017. Crossref, Medline, Web of Science, Google Scholar
    • Tunon, J., L. Badimon, M.L. Bochaton-Piallat, B. Cariou, M.J. Daemen, J. Egido, P.C. Evans, I.E. Hoefer, D.F.J. Ketelhuth, E. Lutgens, C.M. Matter, C. Monaco, S. Steffens, E. Stroes, C. Vindis, C. Weber and M. Back . Identifying the anti-inflammatory response to lipid lowering therapy: A position paper from the working group on atherosclerosis and vascular biology of the European Society of Cardiology. Cardiovasc. Res. 115: 10–19, 2019. Crossref, Medline, Web of Science, Google Scholar
    • Vergani, L., F. Baldini, M. Khalil, A. Voci, P. Putignano and N. Miraglia . New perspectives of S-Adenosylmethionine (SAMe) applications to attenuate fatty Acid-Induced steatosis and oxidative stress in hepatic and endothelial cells. Molecules 25: 4237, 2020. Crossref, Web of Science, Google Scholar
    • Wang, L., Y. Zhao, Q. Zhou, C.L. Luo, A.P. Deng, Z.C. Zhang and J.L. Zhang . Characterization and hepatoprotective activity of anthocyanins from purple sweet potato (Ipomoea batatas L. Cultivar Eshu No. 8). J. Food Drug Anal. 25: 607–618, 2017. Crossref, Medline, Web of Science, Google Scholar
    • Wang, Y., X. Huang, Z. Ma, Y. Wang, X. Chen and Y. Gao . Ophiopogonin D alleviates cardiac hypertrophy in rat by upregulating CYP2J3 in vitro and suppressing inflammation in vivo. Biochem. Biophys. Res. Commun. 503: 1011–1019, 2018. Crossref, Medline, Web of Science, Google Scholar
    • Xiong, Q., L. Zhu, F. Zhang, H. Li, J. Wu, J. Liang, J. Yuan, Y. Shi, Q. Zhang and Y. Hu . Protective activities of polysaccharides from Cipangopaludina chinensis against high-fat-diet-induced atherosclerosis via regulating gut microbiota in ApoE-deficient mice. Food Funct. 10: 6644–6654, 2019. Crossref, Medline, Web of Science, Google Scholar
    • Xu, H.F., J. Luo, W.S. Zhao, Y.C. Yang, H.B. Tian, H.B. Shi and M. Bionaz . Overexpression of SREBP1 (sterol regulatory element binding protein 1) promotes de novo fatty acid synthesis and triacylglycerol accumulation in goat mammary epithelial cells. J. Dairy Sci. 99: 783–795, 2016. Crossref, Medline, Web of Science, Google Scholar
    • Yin, F., G. Sharen, F. Yuan, Y. Peng, R. Chen, X. Zhou, H. Wei, B. Li, W. Jing and J. Zhao . TIP30 regulates lipid metabolism in hepatocellular carcinoma by regulating SREBP1 through the Akt/mTOR signaling pathway. Oncogenesis 6: e347, 2017. Crossref, Medline, Web of Science, Google Scholar
    • Yu, X.H., D.W. Zhang, X.L. Zheng and C.K. Tang . Cholesterol transport system: An integrated cholesterol transport model involved in atherosclerosis. Prog. Lipid Res. 73: 65–91, 2019. Crossref, Medline, Web of Science, Google Scholar
    • Zagato, E., C. Pozzi, A. Bertocchi, T. Schioppa, F. Saccheri, S. Guglietta, B. Fosso, L. Melocchi, G. Nizzoli, J. Troisi, M. Marzano, B. Oresta, I. Spadoni, K. Atarashi, S. Carloni, S. Arioli, G. Fornasa, F. Asnicar, N. Segata, S. Guglielmetti, K. Honda, G. Pesole, W. Vermi, G. Penna and M. Rescigno . Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth. Nat. Microbiol. 5: 511–524, 2020. Crossref, Medline, Web of Science, Google Scholar
    • Zhang, T., F. Huang, B. Li, C. Huang, C. Xu, K. Lin and D. Lin . NMR-based metabolomic analysis for the effects of Huiyang Shengji extract on rat diabetic skin ulcers. J. Ethnopharmacol. 261: 112978, 2020. Crossref, Medline, Web of Science, Google Scholar
    • Zhang, T., J. Huang, Y. Yi, X. Zhang, J.J. Loor, Y. Cao, H. Shi and J. Luo . Akt Serine/Threonine Kinase 1 Regulates de Novo Fatty Acid Synthesis through the Mammalian Target of Rapamycin/Sterol Regulatory Element Binding Protein 1 Axis in Dairy Goat Mammary Epithelial Cells. J. Agric. Food Chem. 66: 1197–1205, 2018. Crossref, Medline, Web of Science, Google Scholar
    • Zhao, L., Q. Zhang, W. Ma, F. Tian, H. Shen and M. Zhou . A combination of quercetin and resveratrol reduces obesity in high-fat diet-fed rats by modulation of gut microbiota. Food Funct. 8: 4644–4656, 2017. Crossref, Medline, Web of Science, Google Scholar
    • Zhou, Y., P. Rychahou, Q. Wang, H.L. Weiss and B.M. Evers . TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium. Cell Death Dis. 6: e1631, 2015. Crossref, Medline, Web of Science, Google Scholar
    • Zhu, X.A., L.F. Gao, Z.G. Zhang and D.K. Xiang . Down-regulation of miR-320 exerts protective effects on myocardial I-R injury via facilitating Nrf2 expression. Eur. Rev. Med. Pharmacol. Sci. 23: 1730–1741, 2019. Medline, Web of Science, Google Scholar
    Remember to check out the Most Cited Articles!

    Check out our Chinese Medicine Titles today.
    Includes titles by Nobel Winner, Tu You You and more!